RecruitingNot ApplicableNCT06857006

Trial of Differential Margins in Single Isocenter Radiosurgery of Brain Metastases

UAB 2507 - Randomized Phase II Study of Differential Margins in Single Isocenter Radiosurgery of Brain Metastases


Sponsor

University of Alabama at Birmingham

Enrollment

180 participants

Start Date

Apr 8, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Radiosurgery is the use of a focal high dose of radiation therapy to ablate or kill a tumor. This trial will enroll patients with brain metastases 4 cm or less in greatest diameter and will compare 0mm margin to a 2mm margin for treatment.


Eligibility

Min Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether using different radiation margin sizes when delivering stereotactic radiosurgery (a precise, high-dose radiation technique) to multiple brain metastases in a single session affects treatment outcomes and side effects. **You may be eligible if...** - You are 19 years or older (male or female) - You have been diagnosed with brain metastases (cancer that has spread to the brain) - Your brain metastases have not been treated before at the same location - You are able to have an MRI scan **You may NOT be eligible if...** - You are pregnant - You received cytotoxic chemotherapy within 3 days of treatment - You are taking certain targeted drugs (like BRAF inhibitors) within 24 hours of treatment - You are enrolled in another drug study within 14 days - You are only receiving radiation to a post-surgical cavity with no remaining visible tumor Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREbrain metastases radiosurgery

Radiosurgery is the use of a focal high dose of radiation therapy to ablate or kill a tumor. This trial will enroll patients with brain metastases 4 cm or less in greatest diameter and will compare 0mm margin to a 2mm margin for treatment.


Locations(1)

University of Alabama at Birmingham (UAB) Hazelrig-Salter Radiation Oncology Center

Birmingham, Alabama, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06857006


Related Trials